Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
Authors
Hira Rizvi,
Francisco Sánchez-VegaKonnor La,
Walid Chatila,
Philip Jonsson,
Darragh Halpenny,
Andrew Plodkowski,
Niamh Long,
Jennifer Sauter,
Natasha Rekhtman,
Travis Hollmann,
Kurt Schalper,
Justin Gainor,
Ronglai Shen,
Ai Ni,
Kathryn Arbour,
Taha Merghoub,
Jedd Wolchok,
Alexandra Snyder,
Jamie Chaft,
Mark Kris,
Charles Rudin,
Nicholas Socci,
Michael Berger,
Barry Taylor,
Ahmet Zehir,
David Solit,
Maria Arcila,
Marc Ladanyi,
Gregory Riely,
Nikolaus Schultz,
Matthew Hellmann +30 authors
,
Francisco Sanchez‐Vega Tip Tip